Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Seminomas Liked to Gene Overexpression

By Biotechdaily staff writers
Posted on 25 Jun 2002
A study has shown that overexpression of a gene called hiwi, a member of the piwi family of genes, is indicative of germ cell testicular tumors, called seminomas. More...
The piwi genes are highly conserved during evolution and play essential roles in stem cell self-renewal, gametogenesis, and RNA interference in diverse organisms. The findings were published in the June 6, 2002, issue of Oncogene.

Researchers from Duke University Medical Center (Durham, NC, USA) found that in seminomas, the reproductive stem cells expressed the hiwi gene at an unusually high rate. The gene activity in the cancer samples was up to 16 times higher than that of a healthy patient. Although the patient sample size was small (12 of 19 patients, or 63%, expressed the hiwi gene in abnormally high levels), the findings were considered to be statistically significant. The hiwi gene was mapped to a region on the long arm of chromosome 12, previously linked to the development of seminomas and other testicular cancers.

"There are several other genes known to be associated with testicular cancer at very low frequencies (10 % or lower). This is the first study to establish a high level correlation between a gene and seminoma,” said Dr. Haifan Lin. Dr. Lin believes that an underactive or nonactive hiwi gene can cause sterility in men because the same gene in drosophila and mice, called piwi and miwi, respectively, are known to cause sterility.

Overexpression of the hiwi gene was not detected in a different type of testicular cancer called nonseminoma. Nor was overexpression detected in spermatocytic seminomas, which are benign testicular tumors that originate from germ cells. Also, hyperactivity of the hiwi gene was not found in testicular tumors caused by overproliferation of somatic cells in the testes.

The investigators hope that the results of this study could lead to genetic testing to predict the risk for developing seminoma. They could also lead to new treatments in affected individuals by genetically reprogramming the reproductive cells to multiply at safe levels. There is also the possibility of developing stem cell therapy to cure infertility due to defects in hiwi-related regulatory processes.





Related Links:
Duke Univ.

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.